ABC Arbitrage’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-403,460
Closed -$5.83M 424
2026
Q1
$5.83M Sell
403,460
-69,524
-15% -$997K 0.77% 25
2025
Q4
$6.74M Buy
+472,984
New +$4.65M 0.63% 32

Other funds holding FOLD

ABC Arbitrage's FOLD Position: Q2 2026 in Review

ABC Arbitrage sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 403,460 shares — an estimated $5.83M sold.

ABC Arbitrage first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $6.74M in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • ABC Arbitrage reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • ABC Arbitrage sold 403,460 Amicus Therapeutics shares in Q2 2026, an estimated $5.83M.
  • ABC Arbitrage first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • ABC Arbitrage's Amicus Therapeutics position peaked at $6.74M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.